TDOC
Get informed when a big investor buys or sells
+ FollowUndervalued by 207.1% based on the discounted cash flow analysis.
| Market cap | $1.37 Billion |
|---|---|
| Enterprise Value | $1.72 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.14 |
| Beta | 2.08 |
| Outstanding Shares | 179,122,268 |
| P/E Ratio | -7.96 |
|---|---|
| PEG | 25.39 |
| Price to Sales | 0.51 |
| Price to Book Ratio | 1.01 |
| Enterprise Value to Revenue | 0.68 |
| Enterprise Value to EBIT | -8.83 |
| Enterprise Value to Net Income | -11 |
| Total Debt to Enterprise | 0.64 |
| Debt to Equity | 0.82 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.7326▼ 43.68% |
|---|---|
| Total Calls | 5,683,610▲ 17.42% |
| Total Puts | 4,163,800▼ 26.44% |
Holdings and activity of institutional investors.
| Ownership % | 81.29%▲ 6.00% |
|---|---|
| Total Invested | $782.65M▼ 15.54% |
| Investors Holding | 347▼ 26.00% |
No data
Teladoc Health empowers all people everywhere to live their healthiest lives by transforming the healthcare experience. As the world leader in whole-person virtual care, Teladoc Health uses proprietary health signals and personalized int...
As the primary committee for taxation, trade, and entitlement spending, Finance directly impacts Teladoc Health through corporate tax policy, and crucially, through its control over Medicare and Medicaid reimbursement rates and coverage, which are vital for virtual care providers.
This committee is responsible for allocating federal spending. Its decisions directly impact funding for healthcare programs (e.g., Medicare, Medicaid, VA healthcare), which are significant potential revenue streams and regulatory environments for Teladoc Health.
This committee directly regulates core aspects of the healthcare industry, including the FDA and NIH, and influences labor laws. Its decisions on healthcare policy, standards, and scope of practice for telehealth directly impact Teladoc Health's operations, services, and market opportunities.